Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Raphaël Clère-Jehl, Drifa Belhadi et al.|The Lancet Infectious Diseases|2021Cited by 344
Type 1 Diabetes in People Hospitalized for COVID-19: New Insights From the CORONADO StudyBruno Mégarbane, Pierre Gourdy, Lisa Ludwig et al.|Diabetes Care|2020Cited by 48
Prevalence and risk factors of significant persistent pain symptoms after critical care illness: a prospective multicentric studyAlexandre Bourdiol, Jean‐Noël Evain, Vincent Legros et al.|Critical Care|2023Cited by 19